AtriCure greenshoe exercised, raising IPO to $49.8 million

New York, Aug. 10 - AtriCure, Inc. said the underwriters of its initial public offering of common stock exercised the 600,000 share greenshoe in full, raising the size of the deal to 4.6 million shares.

Of the over-allotment option, AtriCure sold 150,000 shares, raising its part of the deal to 4.15 million shares or $49.8 million, while selling shareholders accounted for the remaining 450,000.

AtriCure originally priced the IPO after the close on Aug. 4 at $12.00 per share.

UBS Investment Bank and Piper Jaffray & Co. were joint bookrunners for the offering. Thomas Weisel Partners LLC and A. G. Edwards & Sons, Inc. were co-managers.

AtriCure, a West Chester, Ohio, manufacturer of surgical devices, plans to use $6.5 million of the funds to acquire Enable Medical Corp., with the rest of the money set aside for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.